Testicular Synovial Sarcoma: A Case Report

References

1. ↵
   2. Bergh P,
   3. Jeanne M,
   4. Gherlizionne F et al.

   Synovial sarcoma: identification of low and high risk groups. Cancer 1999; 85: 2596–2607.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   2. Eilber FC,
   3. Dry SM.

   Diagnosis and management of synovial sarcoma. J Surg Oncol 2008; 97: 314–320.

   OpenUrlCrossRefPubMed
3. ↵
   2. Fernebro J,
   3. Francis P,
   4. Eden P, et al.

   Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Int J Cancer 2006; 118: 1165–1172.

   OpenUrlCrossRefPubMed
4. ↵
   2. Lewis JJ,
   3. Antonescu CR,
   4. Leung DH, et al.

   Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000; 18: 2087–2094.

   OpenUrlAbstract/FREE Full Text
5. ↵
   2. Rosen G,
   3. Forscher C,
   4. Lowenbraun S, et al.

   Synovial sarcoma: Uniform response of metastases to high dose ifosfamide. Cancer 1994; 73: 2506–2511.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   2. Lai JP,
   3. Rosenberg AZ,
   4. Miettinen MM, et al.

   NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target. Oncoimmunology 2012; 1: 1409–1410.

   OpenUrl
7. ↵
   2. Robbins PF,
   3. Morgan RA,
   4. Feldman SA, et al.

   Tumor regression in patients with metastatic synovial sarcoma cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol 2011; 29: 917–924.

   OpenUrlAbstract/FREE Full Text